trilaciclib,Trastuzumab,Tucatinib
merck,agenus,g1 therapeutics,seagen,roche
[]
$sgen and $mrk
excellent to see another therapeutic option for patients with colorectal cancer.
it will be interesting to see $agen's data on saturday at #ascogi23 and $gthx's data next month re: trilaciclib with chemo in colorectal. 
Biotech Patent Attorney (founder of Double Helix Law) 
Biopharma Investor/entrepreneur (founder AMP Biotech Research & https://t.co/UH5EKcyFkj). JD, PhD patent attorney, IL&CA